$7.17
-0.43-5.66%
At close: Sep 9, 5:00 PM EST
$7.55
0.385.3%
After Hours: Sep 8, 6:30 PM EST
OptimizeRx Corp
OPRXNASDAQ
OptimizeRx Earnings & Forecasts
OptimizeRx (OPRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
OptimizeRx Guidance
OptimizeRx (OPRX) last issued guidance on August 12, 2026 for fiscal year 2026. The company guided revenue in the range of $95M - $100M for the period.
Compared to prior guidance, OptimizeRx maintained its revenue forecast from a prior range of $95M - $100M.
OptimizeRx has issued 15 guidance updates between November 8, 2022 and August 12, 2026. During this period, the company raised its outlook 8 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.09 | $-0.02 | $0.18 | $-0.01 |
| Actual | $0.16 | $0.14 | $0.51 | $0.20 |
| Surprise | +77.8% | +800.0% | +183.3% | +2100.0% |
| Revenue | ||||
| Estimate | $20.3M | $18.4M | $31.2M | $23.7M |
| Actual | $20.5M | $19.8M | $32.2M | $26.1M |
| Surprise | +1.21% | +8.01% | +3.39% | +10.1% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.15 | $0.40 | $0.09 | $0.12 |
| Revenue | ||||
| Consensus | $21.7M | $34.6M | — | — |
